Therapeuticsmd, inc. (TXMD)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Product revenue, net

57,950

49,646

38,834

18,588

16,272

16,099

15,134

16,078

16,565

16,777

17,140

18,259

18,411

19,356

20,498

20,153

20,597

20,142

18,770

17,766

16,670

15,026

13,631

11,739

10,068

8,775

7,153

5,895

4,633

3,818

3,131

2,634

2,324

2,088

0

0

0

-

-

Cost of goods sold

8,286

6,334

4,406

3,661

2,866

2,737

2,381

2,383

2,610

2,636

2,751

3,288

3,736

4,185

4,711

4,668

4,571

4,506

4,150

4,024

3,884

3,671

3,259

2,839

2,409

1,959

1,825

1,483

1,392

1,348

1,278

1,212

1,079

947

0

0

0

-

-

Gross profit

49,664

43,312

34,428

14,927

13,405

13,361

12,752

13,694

13,954

14,140

14,389

14,970

14,674

15,170

15,786

15,484

16,026

15,636

14,620

13,742

12,785

11,354

10,371

8,900

7,658

6,816

5,328

4,411

3,241

2,469

1,853

1,421

1,244

1,141

0

0

0

-

-

Operating expenses:
Sales, general, and administrative

196,175

174,112

156,789

142,016

130,095

115,988

94,757

76,460

61,622

57,703

59,853

62,517

58,507

51,348

43,650

35,989

32,236

28,721

25,604

24,586

23,258

22,124

20,869

19,578

19,517

19,014

19,501

17,672

15,769

14,069

11,911

10,621

8,248

6,406

0

0

0

-

-

Research and development

16,743

19,792

22,113

24,743

26,577

27,299

31,520

31,249

33,167

33,852

33,219

41,446

46,571

53,943

56,855

58,613

68,962

72,042

72,956

71,443

55,487

43,218

35,192

24,381

17,894

13,551

8,956

6,559

5,645

4,492

2,798

1,191

464

107

0

0

0

-

-

Depreciation and amortization

767

612

459

390

341

293

254

235

223

213

205

191

162

132

102

78

68

62

56

53

52

52

47

66

63

58

63

45

49

56

57

56

55

54

0

0

0

-

0

Operating revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Operating costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

General and administration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Total operating expenses

213,686

194,517

179,361

167,150

157,014

143,581

126,532

107,945

95,013

91,769

93,277

104,155

105,241

105,424

100,608

94,681

101,267

100,826

98,617

96,083

78,798

65,395

56,108

44,026

37,475

32,624

28,520

24,277

21,464

18,618

14,767

11,869

8,768

6,568

0

0

0

0

0

Operating loss

-164,022

-151,205

-144,933

-152,223

-143,608

-130,220

-113,780

-94,250

-81,058

-77,628

-78,888

-89,184

-90,566

-90,253

-84,821

-79,196

-85,241

-85,190

-83,996

-82,341

-66,012

-54,041

-45,737

-35,126

-29,816

-25,808

-23,192

-19,865

-18,223

-16,148

-12,913

-10,447

-7,523

-5,427

0

0

0

-

-

Other income (expense)
Financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

260

656

1,103

1,499

1,503

1,107

659

263

0

0

0

0

-

-

-

-

-

-

Loan guaranty costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

12

24

36

45

46

46

46

38

0

0

0

-

-

Loss on extinguishment of debt

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,307

-17,895

-17,697

-17,697

-7,390

0

0

0

-

-

Miscellaneous income

2,146

2,500

2,702

2,807

2,655

2,280

1,711

1,069

884

695

543

486

451

367

298

216

127

95

66

44

37

46

62

68

53

34

16

5

0

-

0

0

-

-

0

0

-

-

0

Beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

Interest expense

21,554

17,382

13,770

8,703

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,165

1,686

1,820

2,969

1,905

1,432

1,314

166

64

0

0

0

0

0

Accreted interest

-

-

-

-

-

-

-

-

-

7

10

13

12

10

1

1

1

17

33

39

46

37

27

0

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Total other expense

-29,465

-24,939

-21,166

-17,515

-4,112

-2,396

-873

538

888

703

554

499

463

378

300

217

128

113

99

84

84

-176

-538

-990

-1,410

-2,611

-2,593

-2,500

-9,982

-18,971

-26,064

-25,764

-17,904

-7,486

0

0

0

0

0

Loss before income taxes

-193,487

-176,144

-166,100

-169,739

-147,721

-132,617

-114,653

-93,712

-80,170

-76,925

-78,334

-88,685

-90,102

-89,875

-84,521

-78,978

-85,112

-85,077

-83,896

-82,256

-65,928

-54,217

-46,275

-36,116

-31,226

-28,419

-25,785

-22,365

-28,206

-35,120

-38,978

-36,212

-25,428

-12,913

0

0

0

0

0

Provision for income taxes

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

0

-

-

-

-

0

-

-

-

-

0

0

0

0

-

0

0

0

0

0

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain on disposal of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Income (loss) from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net loss

-193,487

-176,144

-166,100

-169,739

-147,721

-132,617

-114,653

-93,712

-80,170

-76,925

-78,334

-88,685

-90,102

-89,875

-84,521

-78,978

-85,112

-85,077

-83,896

-82,256

-65,928

-54,217

-46,275

-36,116

-31,226

-28,419

-25,785

-22,365

-28,206

-35,120

-38,978

-36,212

-25,428

-12,913

0

0

0

0

0

Loss per share, basic and diluted:
From continuing operations, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.01

0.00

From discontinued operations, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.01

-0.01

Net loss per share, basic and diluted

-0.21

-0.20

-0.13

-0.23

-0.16

-0.17

-0.16

-0.15

-0.11

-0.09

-0.07

-0.10

-0.11

-0.11

-0.13

-0.11

-0.11

-0.09

-0.11

-0.16

-0.13

-0.11

-0.12

-0.07

-0.06

-0.05

-0.06

-0.05

-0.06

-0.04

-0.04

-0.14

-0.16

-0.15

-0.03

-0.02

-0.01

0.00

-0.02

Weighted average number of common shares outstanding, basic and diluted

271,459

261,924

241,261

241,221

241,006

238,832

228,107

216,640

216,525

212,980

207,938

203,384

197,790

196,623

196,502

196,325

194,901

179,260

177,206

172,782

163,448

156,203

152,200

145,485

145,019

145,161

131,212

130,851

103,052

99,921

95,895

86,149

84,556

78,492

58,407

57,455

55,710

15,790

15,894

Product [Member]
Total revenue, net

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and Service [Member]
Total revenue, net

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-